Abstract
Parallel visual pathways are initiated at the first retinal synapse by signaling between the rod and cone photoreceptors and two general classes of bipolar cells. For normal function, ON or depolarizing bipolar cells (DBCs) require the G-protein-coupled receptor, mGluR6, an intact G-protein-coupled cascade and the transient receptor potential melastatin 1 (TRPM1) cation channel. In addition, another seven transmembrane protein, GPR179, is required for DBC function and recruits the regulators of G-protein signaling (RGS) proteins, RGS7 and RGS11, to the dendritic tips of the DBCs. Here we use the Gpr179nob5 mouse, which lacks GPR179 and has a no b-wave electroretinogram (ERG) phenotype, to demonstrate that despite the absence of both GPR179 and RGS7/RGS11, a small dark-adapted ERG b-wave remains and can be enhanced with long duration flashes. Consistent with the ERG, the mGluR6-mediated gating of TRPM1 can be evoked pharmacologically in Gpr179nob5 and RGS7−/−/RGS11−/− rod BCs if strong stimulation conditions are used. In contrast, direct gating of TRPM1 by capsaicin in RGS7−/−/RGS11−/− and WT rod BCs is similar, but severely compromised in Gpr179nob5 rod BCs. Noise and standing current analyses indicate that the remaining channels in Gpr179nob5 and RGS7−/−/RGS11−/− rod BCs have a very low open probability. We propose that GPR179 along with RGS7 and RGS11 controls the ability of the mGluR6 cascade to gate TRPM1. In addition to its role in localizing RGS7 and RGS11 to the dendritic tips, GPR179 via a direct interaction with the TRPM1 channel alters its ability to be gated directly by capsaicin.
Introduction
Visual processing in the mammalian retina is initiated through parallel vertical pathways that are established at the synapse between photoreceptors and bipolar cells (BCs). In the dark, photoreceptors constantly release glutamate and in response to a light increment they hyperpolarize, decreasing glutamate release. Two general classes of BCs form synapses with cone photoreceptor terminals and are defined by their response to a light increment. Hyperpolarizing BCs signal via ionotropic glutamate receptors of the AMPA/kainate type (Kaneko and Saito, 1983; Saito and Kaneko, 1983; Slaughter and Miller, 1983) and depolarizing BCs (DBCs) signal via the metabotropic glutamate receptor 6 (mGluR6; Masu et al., 1995). A single class of rod BC is postsynaptic to rod photoreceptors (Boycott et al., 1969). As a result, defects at this synapse lead to complete congenital stationary night blindness (cCSNB). This defect is detected by the absence of the b-wave in the electroretinogram (ERG) in both humans and animal models (Miyake et al., 1986; McCall and Gregg, 2008).
The rod BC light-evoked response is initiated by a decrease in glutamate occupancy of mGluR6, which decreases its G-protein activity culminating in the opening of the TRPM1 channel (Audo et al., 2009; Li et al., 2009; Morgans et al., 2009, 2010; Shen et al., 2009; Koike et al., 2010; Peachey et al., 2012a). The mGluR6-mediated modulation of TRPM1 also is known to require several other proteins including Gαo and Gβ3 (Dhingra et al., 2000, 2002, 2012; Koike et al., 2010), and the regulators of G-proteins Gβ5, RGS7, and RGS11 (Morgans et al., 2007; Jeffrey et al., 2010; Cao et al., 2012). Other known components with unresolved function include the following: nyctalopin, GPR179, and LRIT3 (Gregg et al., 2003; Audo et al., 2012; Peachey et al., 2012b; Zeitz et al., 2013).
GPR179 is a seven transmembrane protein that is absent in the Gpr179nob5 mouse mutant because of a transposable element insertion into the Gpr179 gene, which presents as a recessively inherited no b-wave phenotype in the ERG (Peachey et al., 2012b). GPR179 interacts with and is required for RGS7 and RGS11 localization to the DBC dendritic tips (Orlandi et al., 2012). To gain further insight into the role of GPR179 in the rod BC light response, we studied and compared Gpr179nob5, RGS7−/−/RGS11−/−, and WT mice.
We show that protein expression and outer plexiform layer (OPL) localization of both mGluR6 and TRPM1 are independent of GPR179 expression and that GPR179 and TRPM1 proteins interact. Functional analysis using ERG and whole-cell, patch-clamp recording of rod BCs confirms that TRPM1-mediated currents are present in both Gpr179nob5 and RGS7−/−/RGS11−/− rod BCs, although the sensitivity of the mGluR6 cascade is significantly lower in each compared with WT. The Gpr179nob5 and RGS7−/−/RGS11−/− mutants differ in the direct gating of TRPM1 by capsaicin, which is similar in WT and RGS7−/−/RGS11−/− rod BCs and severely compromised in Gpr179nob5 rod BCs. Together, our results suggest that the sensitivity of the mGluR6 signaling cascade is set by the GPR179/RGS7/RGS11 complex, whereas an interaction between GPR179/TRPM1 sets the sensitivity of gating of the TRPM1 channel.
Materials and Methods
Animals.
All procedures were performed in accordance with the Society for Neuroscience policies on the use of animals in research and each local Institutional Animal Care and Use Committees. Descriptions of all mice used have been published previously (Masu et al., 1995; Pardue et al., 1998; Pearring et al., 2011; Cao et al., 2012; Peachey et al., 2012b) and every line was either generated on a C57BL/6J background or backcrossed onto this background for at least six generations. All mice were housed in local Association for Assessment and Accreditation of Laboratory Animal Care approved facilities under a 12 h light/dark cycle. Animals of either sex were used in the experiments.
Antibodies.
In experiments to examine the pattern of protein expression in the OPL, the following primary antibodies (and their concentrations) were used: sheep anti-GPR179 (1:2000; peptide KVQEETPGEDLDRPVLQKR; Peachey et al., 2012b), mouse monoclonal anti-ctbp2/Ribeye (1:1000; BD Bioscience), guinea pig anti-mGluR6 (1:1000; Koike et al., 2010), sheep anti-TRPM1 (1:1000; Cao et al., 2011), rabbit anti-GFP (1:800), and rhodamine peanut agglutinin (PNA) conjugate 566 (1:1000; Vector Laboratories). Secondary antibodies (Invitrogen; 1:1000) appropriate to each primary antibody included the following: donkey anti-sheep Alexa 488, donkey anti-rabbit Alexa 680, donkey anti-rabbit Alexa 546, donkey anti-mouse Alexa 647, and donkey anti-guinea pig Cy3 (1:1000; Millipore). In lieu of an antibody specific to nyctalopin, we used Tg(Gabrr1-YFP/nyx)Rgg1 transgenic mice, which express a yellow fluorescent protein (YFP)-tagged nyctalopin (Gregg et al., 2007). They are labeled WT in the figures.
Immunochemistry.
Mice were anesthetized, their eyes were enucleated, and the lens was removed. Eyecups were washed in PBS then fixed for 30 min in 4% paraformaldehyde PBS solution, pH 7.4. Eyecups were washed three times in PBS then cryoprotected in increasing concentrations of sucrose in PBS (10%, 15% for 1 h each and 20% overnight). Eyecups were embedded in 2:1 OCT/20% sucrose PBS solution frozen in a liquid nitrogen-cooled bath of isopentane. Eyecups were sectioned (18 μm) using a Leica 1850 cryostat, mounted on glass slides, and stored at −70°C. Sections were warmed to 37°C and washed with PBS and PBS containing 0.05% Triton X-100 (PBX) for 5 min each, then blocked in PBX 5% normal donkey serum blocking solution for 1 h. Sections were incubated overnight at room temperature in the presence of the primary antibody diluted in blocking solution, then washed three times for 10 min each with PBX followed by incubation in secondary antibody in PBX for 1 h at room temperature. Sections were washed for 10 min in PBX twice and in PBS once and coverslipped using Immu-Mount (Thermo Scientific). Slides were imaged using an Olympus FV1000 confocal microscope. Images were universally adjusted for brightness using Photoshop.
Mass spectrometry.
After killing the mice, retinas were isolated from WT mice and homogenized in lysis buffer (1% Nonidet P-40, 2 mm EDTA, and 20 mm HEPES, pH 7.4, supplemented with protease inhibitor cocktail) by rotating at 4°C for 45 min. Samples were centrifuged at 17,000 × g for 20 min to remove the debris, and supernatant was precleaned with Dynabeads (Invitrogen) for 1 h at 4°C. Samples were incubated with TRPM1 or GPR179 antibody overnight at 4°C. Lysates and antibody complexes were incubated with Dynabeads for 1.5 h at 4°C. Protein complexes were eluted with NuPAGE LDS sample buffer (Invitrogen) and electrophoresed on NuPAGE gel (Invitrogen) until the highest molecular weight standard (260 kDa) had moved ∼5 mm into the gel. Electrophoresed gel pieces were cut from the top of the gel and an in-gel tryptic digestion was performed as described previously (Rood et al., 2010).
The resulting peptide mixture was resolved by liquid chromatography (LC) using an EASY n-LC (Thermo Scientific) UHPLC system with buffer A (2% v/v acetonitrile/0.1% v/v formic acid) and buffer B (80% v/v acetonitrile/0.1% v/v formic acid) as mobile phases. The mass spectrometry data from LC elutes was collected using an Orbitrap Elite ETD mass spectrometer (Thermo Scientific). A decision tree was used to determine whether CID or ETD activation was used. Proteome Discoverer v1.3.0.330 was used to analyze the data collected by the mass spectrometer. Scaffold v3.6.5 was used to calculate the false discovery rate using the peptide and protein prophet algorithms.
Cell culture, transfection, and immunoblotting.
Human Embryonic Kidney (HEK293T) cells were cultured in high-glucose DMEM supplemented with 10% fetal bovine serum, 2 mm l-glutamine, 50 IU/ml penicillin, and 50 μg/ml streptomycin. One day before transfection, cells were seeded on 60 mm culture dishes. Gpr179 and Trpm1 expression plasmids were transfected into HEK293T cells using jetPrime reagent (Polyplus transfection) or Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. After 24–48 h of transfection, cells were harvested in NP-40 lysis buffer (50 mm Tris, 150 mm NaCl, 2 mm EDTA, and 1% Nonidet P40, pH 8.0, supplemented with protease inhibitor cocktail; Sigma-Aldrich) by rotating for 45 min at 4°C and centrifuged at 17,000 × g for 15 min at 4°C. Protein content was quantified by Bradford reagent (Bio-Rad). Protein lysates were analyzed on 4–12% NuPAGE gels (Invitrogen) or 6% SDS-PAGE gels, transferred to PVDF membranes, and immunoblotted using HRP-conjugated secondary antibodies and ECL West Pico detection system (Thermo Scientific).
Coimmunoprecipitation.
Dissected mouse retinas were homogenized in lysis buffer (1% Nonidet P-40, 2 mm EDTA, and 20 mm HEPES, pH 7.4, supplemented with protease inhibitor cocktail) by rotating at 4°C for 45 min. Homogenates were cleared by centrifugation at 17,000 g for 20 min at 4°C. For coimmunoprecipitation, retinal lysates or transfected HEK cell lysates were precleared by incubating with 12 μl Dynabeads protein G (Invitrogen) at 4°C for 1 h. Precleared lysates were incubated with 2–5 μg of anti-GPR179 or anti-Flag antibodies overnight at 4°C on an orbital rocker. Forty five microliters of Dynabeads protein G was added and incubated for 1–2 h at 4°C. Dynabeads were collected and washed four times with Tris-buffered saline containing 0.3% Tween 20. Protein complexes were eluted with 40 μl of 4× LDS loading buffer by incubation at 70°C for 10 min, separated by SDS-PAGE, and analyzed by immunoblotting.
ERG.
ERG studies were conducted in Cleveland, OH, and at the University of Louisville (UofL). Animals were dark adapted overnight and anesthetized with ketamine (80 mg/kg) and xylazine (16 mg/kg). Eye drops were used to dilate the pupil (1% tropicamide and 2.5% phenylephrine HCl) and to anesthetize the corneal surface (1% proparacaine HCl). ERGs were recorded using stainless steel (strobe flash) or gold (variable duration) electrodes contacting the corneal surface wetted with 1% methylcellulose. Platinum needle electrodes in the cheek and tail serve as reference and ground, respectively. Mice were tested using two ERG recording protocols, which used either a strobe flash or variable duration stimuli. Strobe flash ERGs were recorded using an LKC UTAS E-3000 signal averaging system. Stimuli ranged in luminance from −3.6 to 1.4 log cd s/m2. At UofL the LKC system also was used to record variable duration flash ERGs, whereas in Cleveland a Diagnosys Espion system was used. Both systems used an approximately −1.2 log cd/m2 flash whose duration ranged from 10 to 1000 ms. Because of slight variations in flash levels and procedures between the systems, all ERG data were normalized to WT data from the individual institutions.
Retinal slice preparation and whole-cell, patch-clamp recording.
Mice were anesthetized with an intraperitoneal injection of Ringer's solution containing ketamine/xylazine (127/12 mg/kg, respectively) and killed by cervical dislocation. The eyes were enucleated and the retinas removed and placed in fresh Ames solution (Sigma-Aldrich). The retina was adhered to nitrocellulose paper (Millipore) and then sliced perpendicular to the retinal layers using a tissue slicer. The slices were then placed in a recording chamber. Recording electrodes were pulled from borosilicate glass (FHC) on a P-97 Flaming/Brown Micropipette Puller (Sutter Instruments). Electrode resistance measured between 6 and 9 MΩ. Glass electrodes were filled with intracellular solution that contained Cs-gluconate solution (20 mm CsCl, 107 mm CsOH, 107 mm d-gluconic acid, 10 mm NaHEPES, 10 mm BAPTA, 4 mm ATP, and 1 mm GTP). The intracellular solution contained 1% sulforhodamine to visualize the cell and classify its morphology (Ghosh et al., 2004). Rod BC somas were targeted for whole-cell, patch-clamp recording. A 2–4 GΩ seal was created on the cell body and cells with an input resistance ∼1 GΩ and access resistance <25 MΩ were used for recording. The recording chamber was maintained at 34−35°C.
To block inhibitory inputs, Ames solution was supplemented with the following: 1 μm strychnine, 100 μm picrotoxin, and 50 μm 6-tetrahydropyridin-4-yl methylphosphinic acid. l-AP4 (4 μm) was added to the bath solution to saturate mGluR6 receptors. The mGluR6 receptor antagonist α-cyclopropyl-4-phosphonophenylglycine (CPPG) was dissolved in Ames medium to a working concentration of 0.6 mm or 3 mm. CPPG was applied by pressure application using a Picospritzer II (Parker Instrumentation) onto the rod BC dendritic tips in the OPL. In separate experiments, capsaicin (10 μM), a TRPM1 agonist, was puffed onto the rod BC dendrites to gate the opening of the TRPM1 channel. Reagents were purchased from Sigma-Aldrich, except for l-AP4, CPPG, and capsaicin, which were purchased from Tocris Bioscience.
Voltage-clamp protocols.
Rod BC responses were recorded via a Multiclamp 700A amplifier with a Digidata 1440A digitizer (MDS Analytical Technologies) and filtered at 2.4 kHz with a four-pole Bessel low-pass filter, sampled at 10 kHz. Off-line a 20 Hz eight-pole Bessel low-pass filter was applied to the data. Clampex 10.2 software (MDS Analytical Technologies) was used to generate command outputs and acquire and analyze analog whole-cell current. Rod BCs were voltage clamped at +50mV (Nawy, 2004; Shen et al., 2009). CPPG was puffed at rod BC dendrites for 200 ms and 1 s. For capsaicin experiments 1 s puffs were applied. Three to five responses were recorded from each cell and then averaged. Variance and standing current were measured across the first 1.5 s of the recording for each rod BC. Off-line analyses of data were performed using Clampfit 10.2. Prism 5.04 software (GraphPad Software) was used to perform two-way repeated-measures ANOVAs, two-way ANOVAs, one-way ANOVAs, or t tests as suited for the necessary comparison. Statistical significance = p < 0.05.
Results
The localization of mGluR6, TRPM1, and NYX to the DBC dendritic tips is independent of GPR179 expression
Since GPR179 is critical to localization of RGS7 and RGS11 (Orlandi et al., 2012), we examined if it plays a similar role for other DBC cascade proteins. We compared expression and localization of mGluR6, the receptor that initiates DBC signaling and TRPM1, the channel that is ultimately gated by the cascade in WT and Gpr179nob5 retinas. To examine nyctalopin expression, a protein critical to expression/localization of TRPM1 (Pearring et al., 2011), we crossed the Gpr179nob5 allele onto the Tg EYFP-Nyx mice that express EYFP tagged nyctalopin on a WT background (Gregg et al., 2007). The retinal expression patterns of TRPM1, mGluR6, and EYFP-Nyx proteins are indistinguishable between mice with WT alleles at the Gpr179 locus and Gpr179nob5 mice (Fig. 1, WT). The merged images in triple-labeled retinal sections show that TRPM1, mGluR6, and nyctalopin expression overlaps on the dendritic tips of the DBCs.
To determine the dependence of GPR179 expression on OPL localization of mGluR6, nyctalopin, or TRPM1, we reacted retinal sections from WT and mutant mice: Grm6−/− (Grm6 encodes mGluR6), Nyxnob, and Trpm1−/− with antibodies to GPR179 (Peachey et al., 2012b) and used the lectin PNA, to delineate the cone pedicles in the OPL. The pattern of GPR179 expression is indistinguishable across all four mouse strains (Fig. 2A–D). As expected (Peachey et al., 2012b), GPR179 expression is absent in the Gpr179nob5 retina (Fig. 2E).
Although not evident in these images (Figs. 1,2), we observed subtle differences in the level of GPR179 expression across these mutants. To quantify protein expression levels of GPR179 relative to WT, we used Western blotting with retinal lysates from each mutant (Fig. 3A,B). As expected, GPR179 is absent in Gpr179nob5 retinas (the negative control) and is decreased ∼50 and 20% in Grm6−/− and Trpm1−/− retinas, respectively. We also quantified TRPM1 expression levels in WT, Gpr179nob5, and Grm6−/− retinas (Fig. 3C,D). TRPM1 expression is absent in Trpm1−/− retinas (the negative control), decreased ∼30% in Gpr179nob5 retinas, and similar to WT in Grm6−/− retinas. In summary, our data show that GPR179 is localized correctly in the OPL independent of mGluR6, TRPM1, and nyctalopin and that the localization of these proteins is independent of GPR179, although expression levels may be somewhat altered as has been reported for several cascade components by others (Cao et al., 2009, 2012; Zhang et al., 2010; Pearring et al., 2011; Dhingra et al., 2012; Orlandi et al., 2012).
GPR179 and TRPM1 are part of the same protein complex
We and others have shown a physical interaction between TRPM1 and nyctalopin (Cao et al., 2011; Pearring et al., 2011) and between GPR179 and RGS7 and RGS11 (Orlandi et al., 2012). At the resolution of the confocal microscope, GPR179 and TRPM1 colocalize at the DBC dendritic tips (Fig. 3E), suggesting that they may interact. Using an affinity purification by immunoprecipitation (IP) approach and antibodies to GPR179, we immunoprecipitated protein complexes from WT mouse retinal lysates and then identified the coimmunoprecipitated proteins using mass spectrometry. Each experiment resulted in the identification of hundreds to thousands of peptides that could be mapped to hundreds of proteins. IP with antibodies to GPR179 yielded 121 peptides whose identity matched GPR179 and gave a coverage of 55%. Two other peptides were identified as TRPM1 (2% coverage). IP with antibodies to TRPM1 yielded 48 peptides that matched TRPM1 (57% coverage) and 12 that matched GPR179 (9% coverage). As a negative control for the specificity of the antibodies, we performed the identical IP with a nonspecific IgG. None of the peptides in the resulting dataset matched GPR179 or TRPM1, or any other known component of the DBC signal transduction cascade. Additional negative controls included IP with GPR179 antibodies using GPR179nob5 retinal lysate and IP with TRPM1 antibodies using Trpm1−/− retinal lysate. Neither TRPM1 nor GPR179 peptides were identified in the resulting datasets. These data indicate our IP results are specific and that GPR179 and TRPM1 are part of the same protein complex and likely directly interact.
To corroborate the mass spectrometry results that GPR179 and TRPM1 interact directly, we performed IP using lysates from HEK293T cells cotransfected with GPR179 and FLAG-TRPM1 expression vectors (Pearring et al., 2011) as well as WT mouse retinal lysates (Fig. 3F,G). Western blot analyses of singly (Fig. 3F, lanes 1,2) and doubly (Fig. 3F, lane 3) transfected HEK293T cell lysates show that both proteins were expressed. IP with the FLAG antibody (Fig. 3F, lanes 4–6) precipitated FLAG-TRPM1 only in singly transfected cell lysates (Fig. 3F, lanes 4,5) and precipitated both GPR179 and FLAG-TRPM1 from double transfected cell lysates (Fig. 3F, lane 6), indicating protein interaction. To control for possible protein interaction during the lysis procedure, we singly transfected either GPR179 or FLAG-TRPM1 into different HEK293T cell cultures, lysed the cells, and mixed their lysates. IP with the FLAG antibody did not precipitate GPR179 from the mixture (data not shown), supporting our conclusion that GPR179 and TRPM1 interact directly.
We repeated the IP experiments using WT and Gpr179nob5 retinal lysates (Fig. 3G). Both GPR179 and TRPM1 were present in WT retinal lysate (Fig. 3G, lane 1). IP of WT retinal lysates with the GPR179 antibody (Fig. 3G, lanes 3,5) coprecipitated TRPM1 and GPR179 (Fig. 3G, lanes 3,5). As controls, we repeated the IP experiments using retinal lysates from Gpr179nob5 (Fig. 3G, lane 4) or Trpm1−/− (Fig. 3G, lane 6). Neither GRP179 nor TRPM1 were present in precipitates from the Gpr179nob5 retinas (Fig. 3G, lane 4). Only GPR179 was present in precipitates from Trpm1−/− retinas (Fig. 3G, lane 6). Our combined mass spectrometry and IP results support the conclusion that GPR179 and TRPM1 are part of the same synaptic complex and interact directly.
Gpr179nob5 mice have ERG b-waves absent in other cCSNB mouse models
Previous comparisons of the ERG responses of WT and Gpr179nob5 showed a significant reduction in the Gpr179nob5 b-wave and we interpreted this result as a no b-wave phenotype (Peachey et al., 2012b). Although the positive polarity b-waves of the ERG responses from Gpr179nob5 and Trpm1−/− mice compared with WT (Fig. 4A) appeared to be completely missing, upon closer inspection, we found a b-wave-like response, albeit small (∼15–20 μV), to low luminance flashes (−3.6, − 2.4 log cd s/m2) that was consistently present in Gpr179nob5 but absent in Trpm1−/− mice (Fig. 4B; t test; p < 0.001). We missed this response previously because it is evident only when the a-wave and slow PIII components are small in amplitude.
Given the small ERG response and a previous observation that a small response could be evoked in RGS7−/−/RGS11−/− rod BCs to a luminance step (Cao et al., 2012), we examined whether the response could be enhanced by long duration (10–1000 ms), full-field stimuli at −1.2 log cd/m2. To these stimuli WT responses were dominated by the b-wave (Fig. 4C), which grew in amplitude as stimulus duration increased, reaching a plateau at ∼50 ms (Fig. 4D). The same stimuli evoked slow b-waves in both Gpr179nob5 and in RGS7−/−/RGS11−/− mice, which also increased in amplitude with stimulus duration and reached a plateau at ∼500 ms (Fig. 4D). Compared with WT, the b-wave amplitudes of Gpr179nob5 and RGS7−/−/RGS/11−/− mice were significantly smaller (two-way ANOVA; p < 0.001 for both). In contrast, we were not able to record a b-wave from Trpm1−/− mice (Fig. 4C,D) or from two other mouse models of cCSNB, Nyxnob, and Grm6nob3 (data not shown). These results suggest that an mGluR6-mediated modulation of TRPM1 remains despite the absence of GPR179 and/or RGS7 and RGS11. Further, while RGS7 and RGS11 are both absent from the dendrites of GPR179nob mice (Cao et al., 2012), GPR179 is expressed normally in the RGS7−/−/RGS11−/− mice (Fig. 4E).
GPR179 sets the sensitivity of the mGluR6 cascade that modulates TRPM1
Our observations and a previous report show that both mGluR6 and TRPM1 proteins are expressed in the OPL of Gpr179nob5 (Fig. 1) and RGS7−/−/RGS/11−/− (Cao et al., 2012; Fig. 2) retina. The presence of a small ERG b-wave in these mice (Fig. 4) suggests that the mGluR6 and its cascade maintain the capacity to gate the TRPM1 channel, although the sensitivity is significantly reduced. To examine the capacity of the cascade to gate the channel, we used an approach first described by Nawy (2004) that pharmacologically mimics the mGluR6 cascade activation by light. Retinal slices were bathed in 4 μm l-AP4 to maximally activate the mGluR6 cascade and close TRPM1 channels and CPPG was exogenously applied (puffed) onto the rod BC dendrites to deactivate the cascade and open the TRPM1 channel. We used the same approach and puffs of capsaicin, which is a TRPM1 channel agonist and directly gates the channel. For all recordings, we held rod BCs at +50mV to minimize rundown and, as a consequence, both CPPG and capsaicin puffs evoked outward currents (Figs. 5, 6).
Puffs of CPPG (0.6 mm; an mGluR6 antagonist) onto the dendritic terminals of synaptically isolated WT rod BCs evoked a robust current whose amplitude was similar regardless of puff duration (200 ms or 1 s duration; Fig. 5A; two-way ANOVA: p > 0.05). As a result, in our comparisons WT responses were combined (Fig. 5B). The responses of Gpr179nob5 and RGS7−/−/RGS11−/− rod BCs to 200 ms CPPG puffs were similar but significantly smaller than WT (Fig. 5B; two-way ANOVA: Gpr179nob5 vs RGS7−/−/RGS11−/−, p > 0.05; Gpr179nob5 vs WT, p < 0.001; RGS7−/−/RGS11−/− vs WT, p < 0.001). In contrast to WT, increasing puff duration to 1 s produced significant increases in both Gpr179nob5 and RGS7−/−/RGS11−/− rod BC responses (Fig. 5A,B; two-way ANOVA: p < 0.001 for both comparisons), although again amplitudes were significantly smaller than WT (Fig. 5A,B; two-way ANOVA: p < 0.001 for both comparisons). Increasing the concentration of CPPG to 3 mm had minimal impact on the WT response (Fig. 5C,D), indicating that the mGluR6 cascade is maximally activated by 0.6 mm puffs for 200 ms. Increasing CPPG concentration to 3 mm evoked similar responses in Gpr179nob5 and RGS7−/−/RGS11−/− rod BCs independent of puff duration, although responses were always significantly smaller than WT (Fig. 5C,D; two-way ANOVA:Gpr179nob5 vs RGS7−/−/RGS11−/− 200 ms and 1 s, p > 0.05; Gpr179nob5 vs WT 200 ms and 1 s, p < 0.001; RGS7−/−/RGS11−/− vs WT 200 ms and 1 s, p < 0.001). Together these results suggest that in rod BCs TRPM1 can be gated even when GPR179 expression is absent. The specific role of GPR179 cannot be determined with the reagents at hand, because the effects on cascade sensitivity could be because of its close interaction with TRPM1. However, the fact that it also is required for localization of the RGS complex confounds a simple conclusion.
Because TRPM1 is expressed in both Gpr179nob5 and in RGS7−/−/RGS11−/− rod BCs, we assumed that the capsaicin-evoked current would be mediated by TRPM1. To test this idea, we compared direct activation of the TRPM1 channel using capsaicin in WT, RGS7−/−/RGS11−/−, Gpr179nob5, and Trpm1−/− rod BCs. As observed previously (Shen et al., 2009), capsaicin evokes robust responses in WT rod BCs (Fig. 6A,B) and the capsaicin-evoked current in RGS7−/−/RGS11−/− and WT rod BCs were not significantly different (one-way ANOVA: WT vs RGS7−/−/RGS11−/−, p > 0.05). In contrast, the capsaicin-evoked current in Gpr179nob5 rod BCs was significantly smaller than either WT or RGS7−/−/RGS11−/− rod BCs (one-way ANOVA: 1 s, Gpr179nob5 vs WT, p < 0.001; Gpr179nob5 vs RGS7−/−/RGS11−/−, p < 0.05). This response also was significantly larger than the capsaicin-evoked current in Trpm1−/− rod BCs, which are barely measurable above background noise (one-way ANOVA: Gpr179nob5 vs Trpm1−/−, p < 0.05). These results indicate that it is the presence of GPR179 in both WT and RGS7−/−/RGS11−/− DBCs that allows the TRPM1 channel to be efficiently gated by capsaicin, whereas its absence leads to a TRPM1 channel whose sensitivity to direct gating is significantly reduced.
Given this result, we examined the open probability of TRPM1 channels and compared the magnitude of the standing outward current and its variance in WT, Gpr179nob, and RGS7−/−/RGS11−/− rod BCs. We compared them to Trpm1−/− rod BCs, where the channel is absent. Both the standing outward current and current variance of Gpr179nob5, RGS7−/−/RGS11−/−, and Trpm1−/− rod BCs were similar (Fig. 7B,C; one-way ANOVAs: p > 0.05) and all were significantly lower than WT (one-way ANOVA: standing current: WT vs Gpr179nob5, p < 0.001; WT vs RGS7−/−/RGS11−/−, p < 0.001; WT vs Trpm1−/−, p < 0.001 variance: WT vs Gpr179nob5, p < 0.01; WT vs RGS7−/−/RGS11−/−, p < 0.05; WT vs Trpm1−/− p < 0.01). These data indicate that even though the TRPM1 channel is expressed in Gpr179nob5 and in RGS7−/−/RGS11−/− rod BCs it has an extremely low (near 0) open probability, similar to when the TRPM1 channel is absent. Our data suggest that GPR179 clusters RGS7 and RGS11 close to the TRPM1 channel and also interacts with TRPM1 to alter the ability of the channel to be gated directly by capsaicin.
Discussion
Visual function in starlight depends on the modulation of mGluR6, which gates the TRPM1 channel in rod BCs. In the current view, glutamate binding to mGluR6 (which happens in the dark) activates a trimeric G-protein complex (Nawy and von Gersdorff, 2011), which eventually leads to closure of the TRPM1 channel. Other critical elements of the mGluR6 G-protein cascade expressed on the tips of WT rod BCs are known because they reduce or eliminate this signaling pathway. They include nyctalopin, a leucine-rich repeat protein that is critical for the presence of TRPM1; GPR179, a seven transmembrane domain protein that is required for localization of a regulator of G-protein signaling (RGS) complex that contains RGS7, RGS11, Gβ3, Gβ5, and R9AP; and LRIT3, another leucine-rich repeat protein of unknown function (Gregg et al., 2003; Rao et al., 2007; Jeffrey et al., 2010; Cao et al., 2012; Dhingra et al., 2012; Shim et al., 2012; Zeitz et al., 2013). Our results show that mGluR6, nyctalopin, and TRPM1 continue to be localized to the OPL in the absence of GPR179 (Figs. 1, 2), but that the absence of GPR179 results in the mislocalization of the RGS7/RGS11 complex to the dendritic tips of DBCs containing the mGluR6/TRPM1 signaling complex (Orlandi et al., 2012). In contrast, in the absence of RGS7/RGS11, GPR179 (Fig. 2), mGluR6, nyctalopin, and TRPM1 are expressed.
Careful analyses of the ERG b-wave responses in Gpr179nob5 mice showed a very small b-wave signal that was increased with longer flash duration. Consistent with this result, strong pharmacological activation of mGluR6 in Gpr179nob5 rod BCs produced a response not evident in Trpm1−/− rod BCs. Similar measurements from RGS7−/−/RGS11 −/− mice phenocopy both the ERG and rod BC responses to CPPG seen in the Gpr179nob5 rod BCs. Further, rod BCs from both Gpr179nob5 and RGS7−/−/RGS11 −/− mice had standing currents and variance that were similar to Trpm1−/− rod BCs, indicating a remaining current of unknown identity, which has been noted previously (Morgans et al., 2009). Our current measures do not allow us to discriminate between the roles of GPR179 and the RGS complex in gating the TRPM1 channel opening through the mGluR6 cascade because the RGS complex is mislocalized in the absence of GPR179. However, the presence of GPR179 is required to maximize direct TRPM1 channel gating via capsaicin application, which does not involve the cascade. Capsaicin-mediated gating is altered in GPR179nob5 rod BCs, but is retained in RGS7−/−/RGS11 −/− rod BCs in which GPR179 is expressed normally (Fig. 6). We suggest this unique function of GPR179 is related to its direct protein:protein interaction with TRPM1. Together our results contribute new information to the ongoing construction of this G-protein cascade that is critical to night vision.
When glutamate binds mGluR6, its trimeric G-proteins are activated and GDP is exchanged for GTP on Gα0, producing activated Gα0-GTP and Gβγ, which become disassociated. Both components are membrane bound and likely in close proximity to TRPM1. This means that one or possibly both can interact with TRPM1 and are instrumental in channel closure, either directly or via another intermediate effector, yet to be identified. For the sake of simplicity, we shall discuss either Gα0-GTP or Gβγ as the direct effector. Regardless of the identity of the active component, the interaction must be transient in nature. This view is supported by the fact that even when mGluR6 is maximally activated, either under dark-adapted conditions (Sampath and Rieke, 2004) or in the presence of l-AP4 (Fig. 7), there remains a standing current and nonzero channel open probability referred to as the dark current. Because the two studies were performed using very different protocols (e.g., dark vs APB and holding at −60mV vs +50mV), we did not compare the currents.
Manipulations that reduce the level of the activated Gα0 all decrease either the light response or response to mGluR6 antagonists. These include adding GTP-γ-S to the patch pipette, deleting the RGS7/11 complex, or adding activated forms of Gα0 (Sampath and Rieke, 2004; Zhang et al., 2010; Cao et al., 2012; Shen et al., 2012; Shim et al., 2012). However, these manipulations cannot distinguish between the Gα0-GTP and Gβγ models because decreasing Gα0-GDP concentrations necessarily increases free Gβγ. Nawy and von Gersdorff (2011) found introduction of active Gβγ but not Gα0 blocked the light response, and suggested Gβγ as the active component in TRPM1 channel closure (Shen et al., 2012). Our studies now show that the RGS complex is not required for cascade function, because in their absence a b-wave remains and the TRPM1 channel can be gated by strong mGluR6 cascade stimulation. Further, our studies show that in the absence of localized RGS proteins the standing current and channel open probability decrease to background levels, in contrast to what is seen when the cascade is maximally activated (Fig. 7). We propose this occurs in GRP179nob5 and RGS7−/−/RGS11 −/− rod BCs because of increased concentrations of both Gα0-GTP and free Gβγ, which arise because of the loss of the RGS complex, resulting in complete TRPM1 closure.
In conclusion, we show that GPR179 interacts with TRPM1 and one of its functions is to localize RGS7 and RGS11 near the signaling complex (Orlandi et al., 2012). A second critical function of GPR179 is to set the state of the TRPM1 channel, allowing it to respond optimally to deactivation of the mGluR6 cascade. Understanding the various states of TRPM1, which we show are dependent on at least GPR179, at the molecular level may provide important clues as to how TRPM1 is gated by the mGluR6 cascade.
Footnotes
This work was supported by funding from the National Institutes of Health (R01 EY12354, R.G.G.; R01 014701, M.A.M.; R21 EY21852, N.S.P. and R.G.G.; RO1 EY018139, K.A.M.), the Foundation Fighting Blindness, the Department of Veterans Affairs, and unrestricted grants from Research to Prevent Blindness to the University of Louisville and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
The authors declare no competing financial interests.
- Correspondence should be addressed to either Ronald G. Gregg or Maureen A. McCall, Department of Biochemistry and Molecular Biology, University of Louisville, 319 Abraham Flexner Way, Louisville, KY 40202, ron.gregg{at}louisville.edu or mo.mccall{at}louisville.edu